Max Neeman International Sets Up a New Vertical for Nutraceutical Studies

Tuesday, April 27, 2010 Alternative Medicine News
Email Print This Page Comment
Font : A-A+



RESEARCH TRIANGLE PARK, N.C., April 26 Max Neeman International, a leading Indian CRO, expands its list of services with the formation of an exclusive team to conduct studies on Nutraceuticals. There is an emerging trend in the Nutraceuticals industry (also known as the "Fast Moving Healthcare Goods") and India is one of the fastest growing markets because of world class CROs, R&D facilities, qualified human resources and varied raw materials. These factors, along with special dietary needs of the elderly, are the driving force behind the development of Nutraceuticals and need for CRO collaboration.

The Max Neeman Nutraceutical studies team consists of specialized and experienced endocrinologists, nutritionists and dietitians with sound experience in executing such studies. The team has conducted trials in the areas of pediatric dietary supplements and preoperative infusion of Omega 3 Fatty Acids.

Max Neeman is now structured to serve the special interests of the Nutraceutical industry and is India's leading CRO for Drug Development, Device studies, Data Management, Medical Writing and Electronic Data Capture for Phase I-IV Studies.

About Max Neeman International

Max Neeman International is one of the leading and largest CROs in India. Our specialty is that we offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2000 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 22 cities with 5 regional offices. Contact Donald Swankie, Vice President of Business Development for more information (Donald.swankie@neeman-medical.com/+1.919.424.3345). www.neeman-medical.com

SOURCE Max Neeman International


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook